Page last updated: 2024-09-05

lapatinib and pilocarpine

lapatinib has been researched along with pilocarpine in 2 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(pilocarpine)
Trials
(pilocarpine)
Recent Studies (post-2010) (pilocarpine)
1,9193051,4427,3343401,528

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)pilocarpine (IC50)
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)3.0267
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)3.84
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)3.84
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)3.84
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)3.84

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for lapatinib and pilocarpine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for lapatinib and pilocarpine

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010